Re: What is the best "sleeper" biotech pick currently with potential, but essentially forgotten?
I agree 100% with good_investop93 on ACAD. I mentioned ITCI as I own a large number of shares as it has an approved drug in schizophrenia, could get approved for bipolar and even if it only mildly works, it has been proven safe which will draw the many to try the drug who aren’t doing well on the current drugs they are taking. It only has a 1.5 Billion valuation, has $600 million in cash if I remember correctly and has another drug being tested for heart conditions.
ITCI’s price could easily increase substantially on schizophrenia alone.
Full disclosure I have substantial holdings in both ITCI and ACAD. they are my only two biotech holdings.